Assessment of short-term changes induced by a Dermatophagoides pteronyssinus extract on asthmatic patients. Randomised, double-blind, placebo-controlled trial

Current Drug Delivery

Volumn 8, Issue 2, 2011, Pages 152-158

  Vidal, Carmen ^a   Tabar, Ana I ^b   Figueroa, Javier ^c   Navarro, José A ^d   Sánchez, Cesárea ^e   Orovitg, Agustín ^e   Armisen, Margarita ^a   Echechipía, Susana ^b   Joral, Alejandro ^d   Lizarza, Susana ^d   Lizaso, Ma Teresa ^b   Rodriguez, Virginia ^a   de la Torre, Fernando ^f  

^a HOSPITAL DE CONXO   (Spain)

^b Hospital Materno Infantil Virgen Del Camino   (Spain)

^c HOSPITAL UNIVERSITARIO INSULAR DE GRAN CANARIA   (Spain)

^d HOSPITAL DONOSTIA   (Spain)

^e Ambulatorio Virgen de la Cinta   (Spain)

^f ALK ABELLÓ   (Denmark)

Author keywords

Allergic asthma; Dermatophagoides pteronyssinus; Short term effect; Skin prick test; Specific IgG4; Subcutaneous immunotherapy

Indexed keywords

BUDESONIDE; CETIRIZINE; HOUSE DUST ALLERGEN; IMMUNOGLOBULIN G4; NOVOPULM; PANGRAMIN PLUS; PLACEBO; SALBUTAMOL SULFATE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ALLERGIC ASTHMA; ARTICLE; ASTHMA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DERMATOPHAGOIDES PTERONYSSINUS; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; HUMAN; IMMUNOTHERAPY; IN VITRO STUDY; IN VIVO STUDY; MALE; MULTICENTER STUDY; NONHUMAN; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SKIN SENSITIZATION; SKIN TOLERANCE INDEX; SUBCUTANEOUS IMMUNOTHERAPY; TREATMENT DURATION;

ADOLESCENT; ADULT; ALLERGENS; ANIMALS; ANTI-ALLERGIC AGENTS; ANTIGENS, DERMATOPHAGOIDES; ASTHMA; BUDESONIDE; DERMATOPHAGOIDES PTERONYSSINUS; DESENSITIZATION, IMMUNOLOGIC; DOUBLE-BLIND METHOD; FEMALE; HUMANS; IMMUNOGLOBULIN G; MALE; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; SKIN TESTS; TISSUE EXTRACTS; YOUNG ADULT;

EID: 79551635510     PISSN: 15672018     EISSN: None     Source Type: Journal    
DOI: 10.2174/156720111794479871     Document Type: Article

References (27)

1. Clark, N.M.; Brown, R.W.; Parker, E.; Robins, T.G.; Remick, D.G. Jr.; Philbert, M.A.; Israel, B.A. Childhood Asthma. Environ. Health. Perspect., 1999, 107 (3), 421-429.
2. Soriano, J.B.; Anto, J.M.; Sunyer, J.; Tobías, A.; Kogevinas, M.; Almar, E.; Moniozguren, M.; Sánchez, J.L.; Palenciano, L.; Burney, P. Risk of asthma in the general Spanish population attributable to specific immunoresponse. Spanish Group of the European Community Respiratory Health Survey. Int. J. Epidemiol., 1999, 28(4), 728-734.
3. Sunyer, J.; Jarvis, D.; Pekkanen, J.; Chinn, S.; Janson, C.; Leynaert, B.; Luczynska, C.; García-Esteban, R.; Burney, P.; Antó, J.M. Geographic variations in the effect of atopy on asthma in the European Community Respiratory Health study. J. Allergy. Clin. Immunol., 2004, 114, 1033-1039.
4. Horak, F. Jr.; Mathews, S.; Ihorst, G.; Arshad, SH.; Frischer, T.; Kuehr, J.; Schwieger, A.; Forster, J. The Space study group. Effect of mite-impermeable mattress encasings and an educational package on the development of allergies in a multinational randomized, controlled birth-cohort study - 24 months results of the Study of Prevention of Allergy in Children in Europe. Clin. Exp. Allergy, 2004, 34(8), 1220-1225.
5. Luczynska, C.; Tredwell, E.; Smeeton, N.; Burney, P. A randomized controlled trial of mite-allergen-impermeable bed covers in adult mite-sensitized asthmatics. Clin. Exp. Allergy, 2003, 33(12), 1648-1653.
6. Cerveri, I.; Locatelli, F.; Zoia, M.C.; Corsico, A.; Accordini, S.; de Marco, R. International variations in asthma treatment compliance: the results of the European Community Respiratory Health Survey [ECHRS]. Eur. Respir. J., 1999, 14(2), 288-294.
7. Lacasse, Y.; Archibald, H.; Ernst, P.; Boulet, L.P. Patterns and determinants of compliance with inhaled steroids in adults with asthma. Can. Resp. J., 2005, 12, 211-217.
8. Williams, L.K.; Pladevall, M.; Xi, H.; Peterson, E.L.; Joseph, C.; Lafata, J.E.; Ownby, D.R.; Johnson, C.C. Relationship between adherence to inhaled corticosteroids and poor outcomes among adults with asthma. J. Allergy Clin. Immunol., 2004, 14(6), 1288-1293.
9. WHO Position Paper. Allergen Immunotherapy: therapeutic vaccines for allergic diseases. Bousquet J, Lockey RF, Malling HJ, Eds. Allergy, 1998, 44(53), 5-42.
10. des Roches, A.; Paradis, L.; Menardo, J.L.; Bouges, S.; Daurés, J.P.; Bousquet, J. Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. VI. Specific immunotherapy prevents the onset of new sensitizations in children. J. Allergy Clin. Immunol., 1997, 9, 450-453.
11. Olaguibel, J.M.; Tabar, A.I.; García, B.E.; Martín, S.; Rico, P. Long-term immunotherapy with an optimal maintenance dose of a standardized Dermatophagoides pteronyssinus extract in asthmatic patients. J. Invest. Allergol. Clin. Immunol., 1999, 9(2), 110-116.
12. Olsen, O.T.; Larsen, K.R.; Jacobsen, L.; Svendsen, U.G. A 1-year, placebo controlled, double blind house-dust-mite immunotherapy study in asthmatic adults. Allergy, 1997, 52, 853-859.
13. Abramson, M.; Puy, R.; Weiner, J. Immunotherapy in asthma: an updated systematic review. Allergy, 1999, 54, 1022-1041.
14. Olaguibel, J.M.; Tabar, A.I.; García, B.E.; Cortés, C. Immunotherapy with standardized extract of Dermatophagoides pteronyssinus in bronchial asthma: a dose-titration study. Allergy, 1997, 52, 168-178.
15. Tabar, A.I.; Muro, M.D.; García, B.E.; Alvarez, M.J.; Acero, S.; Rico, P.; Olaguibel, J.M. Dermatophagoides pteronyssinus cluster immunotherapy. A controlled trial of safety and clinical efficacy. J. Invest. Alergol. Clin. Immunol., 1999, 9(3), 155-164.
16. González de la Cuesta, C.; Feijoo, R.; Rico, P. A prospective safety-monitoring study of immunotherapy in mite-allergy patients with mass-units-standardized extract. Allergy, 1997, 52, 580-583.
17. Tabar, A.I.; Fernández-Távora, L.; Alonso, R.; Castillo, R.; Cisteró- Bahima, A.; de la Torre-Morín, F.; Fernández, J.; García- Figueroa, B.E.; Fernández, S.; García-González, J.J.; García- Robaina, J.C.; Moreno, F.; Lobatón, P.; Sánchez-Machín, I.; de la Torre-Martínez, F. Tolerance of a cluster schedule with a house dust mite extract quantified in mass units: multicentre study. J. Invest. Allergol. Clin. Immunol., 2004, 14(3), 193-197.
18. Nanda, A.; O'Connor, M.; Anand, M.; Dreskin, S.C.; Zhang, L.; Hines, B.; Lane, D.; Wheat, W.; Routes, J.M.; Sawyer, R.; Rosenwasser, L.J.; Nelson, H.S. Dose dependence and time course of the immunologic response to administration of standardized cat allergen extract. J. Allergy. Clin. Immunol., 2004, 114, 1339-1344.
19. Tabar, A.I.; Echechipía, S.; García, B.E.; Olaguibel, J.M.; Lizaso, M.T.; Gómez, B.; Aldunate, M.T.; Martín, S.; Marcotegui, F. Double-blind comparative study of cluster and conventional immunotherapy schedules with Dermatophagoides pteronyssinus. J. Allergy. Clin. Immunol., 2005, 116, 109-118.
20. Juniper, E.F.; O'Byrne, P.M.; Guyatt, G.H.; Ferrie, P.J.; King, D.R. Development and validation of a questionnaire to measure asthma control. Eur. Respir. J., 1999, 14, 902-907.
21. Dreborg, S. Allergen standardisation and skin tests. EAACI Position Paper. Allergy, 1993, 48 (Supl.1), 49-82.
22. Torres Costa, JC.; Plácido, J.L.; Moreira Silva, J.P.; Delgado, L.; Vaz, M. Effects on immunotherapy on symptoms, PEFR, spirometry, and airway responsiveness in patients with allergic asthma to house-dust mites (D. pteronyssinus) on inhaled steroid therapy. Allergy, 1996, 51, 238-244.
23. Shaikh, WA. Immunotherapy vs inhaled budesonide in bronchial asthma: an open, parallel, comparative trial. Clin. Exp. Allergy., 1997, 27, 1279-1284.
24. Ohashi, Y.; Nakai, Y.; Tanaka, A.; Kakinoki, Y.; Washio, Y.; Yamada, K.; Sakamoto, H.; Nasako, Y.; Hayashi, M.; Nakai, Y. A comparative study of the clinical efficacy of immunotherapy and conventional pharmacological treatment for patients with perennial allergic rhinitis. Acta. Otolaryngol., 1998, 538, 102-112.
25. Rak, S.; Heinrich, Ch.; Jacobsen, L.; Scheynius, A.; Venge, P. A double-blind, comparative study of the effects of short preseason specific immunotherapy and topical steroids in patients with allergic rhinoconjunctivitis and asthma. J. Allergy. Clin. Immunol., 2001, 108, 921-928.
26. Rak, S.; Heinrich, C.; Scheynius, A. Comparison of nasal immunohistology in patients with seasonal rhinoconjunctivitis treated with topical steroids or specific allergen immunotherapy. Allergy, 2005, 60, 643-649.
27. Möbs, Ch.; Slotosch, C.; Löffler, H.; Pfützner, W.; Hert, M. Cellular and humoral mechanisms of Immune tolerance in immediatetype allergy induced by specific immunotherapy. Int. Arch. Allerg Immunol., 2008, 147, 171-178.